• Users Online: 617
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Pharmacologic approaches against Advanced Glycation End Products (AGEs) in diabetic cardiovascular disease

Nenna Antonio, Nappi Francesco, Avtaar Singh Sanjeet Singh, Sutherland Fraser W, Di Domenico Fabio, Chello Massimo, Spadaccio Cristiano

Year : 2015| Volume: 4| Issue : 2 | Page no: 5-5

   This article has been cited by
 
1 Advanced Glycation End Products: New Clinical and Molecular Perspectives
Juan Salazar,Carla Navarro,Ángel Ortega,Manuel Nava,Daniela Morillo,Wheeler Torres,Marlon Hernández,Mayela Cabrera,Lissé Angarita,Rina Ortiz,Maricarmen Chacín,Luis D’Marco,Valmore Bermúdez
International Journal of Environmental Research and Public Health. 2021; 18(14): 7236
[Pubmed]  [Google Scholar] [DOI]
2 Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study
Diana Nabrdalik-Lesniak,Katarzyna Nabrdalik,Katarzyna Sedlaczek,Patryk Glówczynski,Hanna Kwiendacz,Tomasz Sawczyn,Weronika Hajzler,Karolina Drozdz,Mirela Hendel,Krzysztof Irlik,Pawel Stelmach,Piotr Adamczyk,Andrzej Paradysz,Slawomir Kasperczyk,Tomasz Stompór,Janusz Gumprecht,Ilaria Peluso
Oxidative Medicine and Cellular Longevity. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
3 Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products
Tomoka Nakamura,Tetsuro Tsujimoto,Kazuki Yasuda,Daisuke Chujo,Mitsuru Ohsugi,Akiyo Tanabe,Kohjiro Ueki,Hiroshi Kajio
Medicine. 2019; 98(30): e16573
[Pubmed]  [Google Scholar] [DOI]
4 Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes
Ping Yang,Jian Feng,Qing Peng,Xing Liu,Zhongcai Fan
Oxidative Medicine and Cellular Longevity. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
5 Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation
Sarah Kassab,Paul Begley,Stephanie J. Church,Sanziana M. Rotariu,Cleo Chevalier-Riffard,Andrew W. Dowsey,Alexander M. Phillips,Leo A.H. Zeef,Ben Grayson,Joanna C. Neill,Garth J.S. Cooper,Richard D. Unwin,Natalie J. Gardiner
Molecular Metabolism. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Caloric restriction improves the redox homeostasis in the aging male rat heart even when started in middle-adulthood and when the body weight is stable
B. Simsek,K. Yanar,A. D. Kansu,A. Belce,S. Aydin,U. Çakatay
Biogerontology. 2018;
[Pubmed]  [Google Scholar] [DOI]
7 Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism
Annunziatina Laurino,Laura Raimondi
Frontiers in Endocrinology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
8 Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
John R. Petrie,Tomasz J. Guzik,Rhian M. Touyz
Canadian Journal of Cardiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Kidney, heart and brain: three organs targeted by ageing and glycation
Marie Frimat,Maité Daroux,Rachel Litke,Rémi Nevičre,Frédéric J. Tessier,Eric Boulanger
Clinical Science. 2017; 131(11): 1069
[Pubmed]  [Google Scholar] [DOI]
10 The Association between Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance T1 Mapping and Myocardial Dysfunction in Diabetic Rabbits
Mu Zeng,Yingyan Qiao,Zhaoying Wen,Jun Liu,Enhua Xiao,Changlian Tan,Yibin Xie,Jing An,Zishu Zhang,Zhanming Fan,Debiao Li
Scientific Reports. 2017; 7: 44937
[Pubmed]  [Google Scholar] [DOI]
11 Amino Carbonylation of Epidermal Basement Membrane Inhibits Epidermal Cell Function and Is Suppressed by Methylparaben
Haruka Morimoto,Lihao Gu,Haifeng Zeng,Kazuhisa Maeda
Cosmetics. 2017; 4(4): 38
[Pubmed]  [Google Scholar] [DOI]
12 Tiny molecule, big power: Multi-target approach for curcumin in diabetic cardiomyopathy
Vengadeshprabhu Karuppagounder,Somasundaram Arumugam,Vijayasree V. Giridharan,Remya Sreedhar,Rajendran J.C. Bose,Jyothi Vanama,Suresh S. Palaniyandi,Tetsuya Konishi,Kenichi Watanabe,Rajarajan A. Thandavarayan
Nutrition. 2017; 34: 47
[Pubmed]  [Google Scholar] [DOI]
13 Glycation, antiglycation, and deglycation: Their role in aging mechanisms and geroprotective effects (literature review)
V. V. Emel’yanov
Advances in Gerontology. 2017; 7(1): 1
[Pubmed]  [Google Scholar] [DOI]
14 Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions
Remi Neviere,Yichi Yu,Lei Wang,Frederic Tessier,Eric Boulanger
Glycoconjugate Journal. 2016; 33(4): 607
[Pubmed]  [Google Scholar] [DOI]
15 Cellular mechanisms and consequences of glycation in atherosclerosis and obesity
Raquel López- Díez,Alexander Shekhtman,Ravichandran Ramasamy,Ann Marie Schmidt
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2016; 1862(12): 2244
[Pubmed]  [Google Scholar] [DOI]
16 Computational approaches in the rational design of improved carbonyl quenchers: focus on histidine containing dipeptides
Giulio Vistoli,Mara Colzani,Angelica Mazzolari,Danilo De Maddis,Giovanni Grazioso,Alessandro Pedretti,Marina Carini,Giancarlo Aldini
Future Medicinal Chemistry. 2016; 8(14): 1721
[Pubmed]  [Google Scholar] [DOI]
17 Cells and extracellular matrix interplay in cardiac valve disease: because age matters
Cristiano Spadaccio,Pamela Mozetic,Francesco Nappi,Antonio Nenna,Fraser Sutherland,Marcella Trombetta,Massimo Chello,Alberto Rainer
Basic Research in Cardiology. 2016; 111(2)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article